Tamiflu’s Effectiveness Doubted

by Admin on 09/12/09 at 4:58 pm

Widely used antiviral drugs such as Tamiflu and Relenza may not prevent complications such as pneumonia in healthy people, according to a new investigation and analysis.

Go here to see the original:
Tamiflu’s Effectiveness Doubted

One Response to “Tamiflu’s Effectiveness Doubted”

  1. Admin

    Dec 10th, 2009

    This is a great breakthrough.

    Oseltamivir (INN) (pronounced /ɒsəlˈtæmɨvɪr/) is an antiviral drug that slows the spread of influenza (flu) virus between cells in the body by stopping the virus from chemically cutting ties with its host cell—median time to symptom alleviation is reduced by 0.5–1 days. The drug is sold under the trade name Tamiflu and is taken orally in capsules or as a suspension. It has been used to treat and prevent Influenzavirus A and Influenzavirus B infection in over 50 million people since 1999. Oseltamivir becomes active in the body once it passes through the liver.

Leave a Reply



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